1H22 Financial Performance

Growth initiatives Growth strategies Benefiting from the continuous expansion of the global medical industry, Weigao plans to build a platform and provide systematic solutions to accelerate future growth Strategic Acquisitions • Replicating the success of Argon and Rad Source by strategically explore acquisition opportunities to broaden our product portfolio and global market coverage and further increase our scale 06 STRATEGIC ACUISITIONS PRODUCT UPGRADES AND DIVERSIFICATION 01 • Product Upgrades and Diversification Focus future developments on higher • technology and higher margin products where barriers to entry are greater Continuing to diversify our product mix to better combat the evolving market Direct Sales Channels Establishing direct sales channels for select product lines in order to provide Weigao with greater pricing power and in turn, higher margins 05 $ DIRECT SALES CHANNELS WEGO感高 $1 IMPORT SUBSTITUTION 02 Import Substitution Tapping into the high-tech markets Importing cutting edge technology to meet the growing demands of Chinese consumers Product Partnerships 04 • Partnering with key customers to design bespoke products to better suit client needs WEGO威高 PRODUCT PARTNERSHIPS STRATEGIC COLLABORATION 03 Strategic Collaboration Adopt open and diverse cooperation to introduce external capital and expertise to foster further innovation 16

View entire presentation